Data / Form D filings / Novosteo Inc.
Novosteo Inc.: Form D filings
Novosteo Inc., a pharmaceuticals company in West Lafayette, IN, filed 4 Form D notices with the SEC between 2021 and 2022. The latest, on April 21, 2022, reports $17.7 million sold of a $17.7 million offering to 37 investors.
Find out what Novosteo Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1281 WIN HENTSCHEL BLVD., West Lafayette, IN, 47906
- Phone
- (765) 761-3912
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2017
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1840600
The full lists. Form D filings in Indiana: 436 rows, $21.80, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 21, 2022 | Amendment | $17,687,040 | $17,687,040 | $0 | 37 | Dec 29, 2020 | sec.gov |
| Nov 22, 2021 | Amendment | $14,289,758 | $8,387,043 | $5,902,715 | 21 | Dec 29, 2020 | sec.gov |
| Nov 10, 2021 | Amendment | $14,289,758 | $5,689,758 | $8,600,000 | 8 | Dec 29, 2020 | sec.gov |
| Jan 14, 2021 | New notice | $6,489,757 | $4,289,758 | $2,199,999 | 6 | Dec 29, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David J. Lamond | Director | |
| Daniel S. Hasler | Director | |
| Dirk Thye, M.D. | Executive Officer, Director | |
| William J. Rutter | Director | |
| Alex S. Andrianopoulos | Director | |
| Philip S. Low, Ph.D. | Executive Officer, Director |
Every Form D from the week of Apr 18, 2022 · All recent filings in Indiana · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Novosteo Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.